NAFLD may influence myocardial ischemia directly or indirectly via mechanisms including insulin resistance, activation of the renin-angiotensin system and sympathetic nervous system, systemic inflammation, oxidative stress, and alterations in gut microbiota (37, 38). This evidence concerns the gene REN and metabolic dysfunction-associated steatotic liver disease.